stoxline Quote Chart Rank Option Currency Glossary
  
(AMPH)
  0 (0%)    09-27 14:26
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-09-26 4:45:45 PM
Short term     
Mid term     
Targets 6-month :  34.14 1-year :  36.51
Resists First :  29.23 Second :  31.26
Pivot price 27.69
Supports First :  25.95 Second :  21.59
MAs MA(5) :  27.07 MA(20) :  28.24
MA(100) :  25.45 MA(250) :  32.3
MACD MACD :  -0.3 Signal :  0
%K %D K(14,3) :  15.3 D(3) :  15.6
RSI RSI(14): 43.2
52-week High :  53.95 Low :  20.38
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ AMPH ] has closed above bottom band by 25.6%. Bollinger Bands are 19.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 26.93 - 27.1 27.1 - 27.25
Low: 25.95 - 26.14 26.14 - 26.33
Close: 26.55 - 26.84 26.84 - 27.11
Company Description

Headline News

Wed, 24 Sep 2025
3 Low-Volatility Stocks with Open Questions - TradingView

Thu, 18 Sep 2025
Is Weakness In Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - simplywall.st

Sat, 13 Sep 2025
MasterVoices in Ivesiade, in The Amph at Little Island (Sept. 13) at The Amph at Little Island - BroadwayWorld.com

Mon, 11 Aug 2025
Why Is Amphastar Pharmaceuticals (AMPH) Stock Soaring Today - Yahoo Finance

Thu, 07 Aug 2025
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance

Thu, 31 Jul 2025
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 47 (M)
Shares Float 35 (M)
Held by Insiders 24 (%)
Held by Institutions 71.8 (%)
Shares Short 4,160 (K)
Shares Short P.Month 4,020 (K)
Stock Financials
EPS 2.67
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 16.29
Profit Margin 18.6 %
Operating Margin 24.1 %
Return on Assets (ttm) 7.3 %
Return on Equity (ttm) 18.3 %
Qtrly Rev. Growth -4.5 %
Gross Profit (p.s.) 7.74
Sales Per Share 15.54
EBITDA (p.s.) 5.09
Qtrly Earnings Growth -12.4 %
Operating Cash Flow 160 (M)
Levered Free Cash Flow 84 (M)
Stock Valuations
PE Ratio 10.05
PEG Ratio 0
Price to Book value 1.64
Price to Sales 1.72
Price to Cash Flow 7.81
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android